Proactive Investors - Run By Investors For Investors

Dyadic International says up-listing to the NASDAQ is 'part of the plan'

Dyadic International Inc (OTCQX: DYAI) Chief Commercial Officer Matthew Jones sat down with Proactive Investors at the BIO CEO and Investor Conference in New York.

Dyadic International, Inc. is a global biotechnology company developing what it believes will be a potentially significant biopharmaceutical gene expression platform named C1.

 
View full DYAI profile View Profile

Dyadic International Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use